Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation. Toronto, ON, May 22, 2019: Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial, St. Michael’s Hospital, in Toronto, has been activated. The trial will be a randomized, placebo-controlled study [...]
Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation. Gallery
Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation.
Neuromodulation News, News Release, Photobiomodulation News, Press Release, Research News, Vielight News